Bleomycin is a Intramuscular; Intrapleural; Intravenous; Subcutaneous Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Bleomycin Sulfate.
Product ID | 71288-106_ae0d7fba-937e-42d1-b7f5-ae6f7b860bc4 |
NDC | 71288-106 |
Product Type | Human Prescription Drug |
Proprietary Name | Bleomycin |
Generic Name | Bleomycin Sulfate |
Dosage Form | Powder, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2018-08-31 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA205030 |
Labeler Name | Meitheal Pharmaceuticals Inc. |
Substance Name | BLEOMYCIN SULFATE |
Active Ingredient Strength | 15 [USP'U]/1 |
Pharm Classes | Cytoprotective Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2018-08-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA205030 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-08-31 |
Ingredient | Strength |
---|---|
BLEOMYCIN SULFATE | 15 [USP'U]/1 |
SPL SET ID: | 640602f9-a7df-46f0-a9b1-19c471008bee |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9240 | Bleomycin | Bleomycin |
0143-9241 | Bleomycin | Bleomycin |
0409-0323 | Bleomycin | BLEOMYCIN |
0409-0332 | Bleomycin | BLEOMYCIN |
0703-3154 | Bleomycin | Bleomycin |
0703-3155 | Bleomycin | Bleomycin |
16714-886 | Bleomycin | Bleomycin |
16714-908 | Bleomycin | Bleomycin |
61703-323 | Bleomycin | BLEOMYCIN |
61703-332 | Bleomycin | BLEOMYCIN |
63323-136 | Bleomycin | BLEOMYCIN SULFATE |
63323-137 | Bleomycin | BLEOMYCIN SULFATE |
69097-364 | Bleomycin | Bleomycin |
70121-1567 | Bleomycin | Bleomycin |
71288-106 | Bleomycin | Bleomycin Sulfate |
71288-107 | Bleomycin | Bleomycin Sulfate |